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Estrogens regulate body weight and reproduction
primarily through actions on estrogen receptor-a
(ERa). However, ERa-expressing cells mediating
these effects are not identified. We demonstrate
that brain-specific deletion of ERa in female mice
causes abdominal obesity stemming from both
hyperphagia and hypometabolism. Hypometabolism
and abdominal obesity, but not hyperphagia, are
recapitulated in female mice lacking ERa in hypotha-
lamic steroidogenic factor-1 (SF1) neurons. In con-
trast, deletion of ERa in hypothalamic pro-opiomela-
nocortin (POMC) neurons leads to hyperphagia,
without directly influencing energy expenditure or
fat distribution. Further, simultaneous deletion of
ERa fromboth SF1 and POMCneurons causes hypo-
metabolism, hyperphagia, and increased visceral
adiposity. Additionally, female mice lacking ERa in
SF1 neurons develop anovulation and infertility,
while POMC-specific deletion of ERa inhibits nega-
tive feedback regulation of estrogens and impairs
fertility in females. These results indicate that estro-
gens act on distinct hypothalamic ERa neurons to
regulate different aspects of energy homeostasis
and reproduction.
INTRODUCTION
Ovarian estrogens exert important antiobesity effects in women
and female mammals. Lower levels of estrogens in postmeno-
pausal women or in ovariectomized (OVX) animals are associ-
ated with obesity (Carr, 2003; Rogers et al., 2009). Estradiol-
17b replacement in rodents prevents OVX-induced obesity by
decreasing food intake and increasing energy expenditure
(Gao et al., 2007). Hormone replacement therapy reverses
the progression of obesity and metabolic dysfunctions in post-
menopausal women (Wren, 2009). However, current hormoneCellreplacement therapy is often associated with increased preva-
lence of heart disease and breast cancer (Billeci et al., 2008).
Because estrogens have both positive and negative effects on
disease progression which are likely mediated by estrogen
receptors (ERs) expressed in a variety of tissues, identification
of the critical ERs and their sites of action is imperative in order
to develop selective estrogen-based therapies which can selec-
tively treat diseases associated with obesity.
Effects of estrogens on energy balance are primarily mediated
by estrogen receptor-a (ERa), as women or female mice with
mutations in the ERa gene display hyperadiposity (Heine et al.,
2000; Okura et al., 2003), characteristically seen in postmeno-
pausal women and OVX animals. However, the critical ERa
sites that mediate estrogenic effects on energy homeostasis
have not been identified. In the present study, we generated
genetic mouse models with ERa selectively deleted in the
central nervous system (CNS), in hypothalamic steroidogenic
factor-1 (SF1) neurons, in pro-opiomelanocortin (POMC)
neurons, or in both SF1 and POMC neurons, respectively. These
models allowed us to identify ERa neuronal populations that
regulate food intake, energy expenditure, fat distribution, and
reproduction.RESULTS
Loss of CNS ERa Impairs Multiple Aspects of Energy
Homeostasis
Validation
To determine if CNS ERa is required for body weight control, we
crossed mice carrying loxP-flanked ERa alleles (ERalox/lox) to the
Nestin-Cre transgenic mice. These crosses producedmice lack-
ing ERa in most brain regions (ERalox/lox/Nestin-Cre) and their
control littermates (ERalox/lox). Using immunohistochemistry,
we demonstrated an almost complete absence of ERa in the
hypothalamus (and other brain regions) in the ERalox/lox/Nestin-
Cre mice (see Figure S1 available online).
Increased Body Weight, Adiposity, and Visceral Fat
Distribution
Compared to controls, both male and female ERalox/lox/Nestin-
Cre mice displayed significant increases in body weightMetabolism 14, 453–465, October 5, 2011 ª2011 Elsevier Inc. 453
Figure 1. CNS ERa Regulates Energy Homeostasis
(A) Weekly body weight in male mice weaned on regular chow (n = 8/genotype).
(B) Weekly body weight in female mice weaned on regular chow (n = 8/genotype).
(C) Body composition in 15-week-old female mice fed with regular chow (n = 8/genotype).
(D) Relative fat distribution in the visceral and subcutaneous depots in 7-week-old female mice fed with regular chow (n = 8 or 10/genotype).
(E) Daily food intake in 7-week-old female mice fed with regular chow (n = 8 or10/genotype).
(F–H) Chow-fed female mice (n = 8 or 10/genotype) were acclimated to the TSE metabolic chambers. Average heat production (F), ambulatory movements (G),
and rearing activities (H) during 24 hr, 12 hr dark cycle and 12 hr light cycle. Note that mice used in (F)–(H) were 12-week-old littermates and had comparable body
weight (ERalox/lox, 22.8 ± 1.5 versus ERalox/lox/Nestin-Cre, 27.2 ± 2.5, p > 0.05) and lean mass (ERalox/lox, 13.80 ± 1.72 versus ERalox/lox/Nestin-Cre, 12.50 ± 0.98,
p > 0.05), but different fat mass (ERalox/lox, 2.80 ± 0.45 versus ERalox/lox/Nestin-Cre, 5.10 ± 0.27, p < 0.001).
(I) Plasma estradiol-17b at diestrus in 7-week-old femalemice fedwith regular chow (n = 8 or 10/genotype). Note thatmice used in (D), (E), and (I) had different total
fat mass (ERalox/lox, 3.53 ± 0.48 versus ERalox/lox/Nestin-Cre, 6.01 ± 1.67, p < 0.05) but comparable lean mass (ERalox/lox, 13.51 ± 0.21 versus ERalox/lox/Nestin-
Cre, 14.10 ± 0.76 (p > 0.05). Data are presented as mean ±SEM, and *p < 0.05 and ***p < 0.001 between ERalox/lox/Nestin-Cre mice and ERalox/lox mice.
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vealed that increases in body weight were mainly reflected by
increased body fat mass (Figure 1C). We further demonstrated
that ERalox/lox/Nestin-Cre female mice had significantly higher
visceral fat distribution (percent of the whole-body fat) but lower
subcutaneous fat distribution (Figure 1D). These data indicate
that CNS ERa is required to regulate body weight, adiposity,
and fat distribution.
Hyperphagia, and Decreased Energy Expenditure
and Physical Activity
ERalox/lox/Nestin-Cre mice displayed hyperphagia (Figure 1E)
and decreased heat production (Figure 1F). The lower energy
expenditure may be partly caused by decreased physical
activity, as the ambulatory movements and rearing activities in
ERalox/lox/Nestin-Cre mice were significantly reduced (Figures
1G and 1H). These results demonstrate that CNS ERa is required
to mediate estrogenic effects on feeding, energy expenditure,
and physical activity.454 Cell Metabolism 14, 453–465, October 5, 2011 ª2011 Elsevier InElevated Plasma Estradiol-17b
Notably, we found that circulating estradiol-17bwas significantly
elevated in ERalox/lox/Nestin-Cre mice (Figure 1I). Our observa-
tions that mice lacking ERa only in the CNS develop obesity
despite the elevated levels of estradiol-17b in the circulation
suggest that, compared to ERa expressed in the peripheral
tissues, CNS ERa appears to play more predominant roles in
the regulation of energy balance.
Loss of ERa in VMH SF1 Neurons Affects Energy
Expenditure and Fat Distribution
Validation
The ventromedial hypothalamic nucleus (VMH) is important for
regulation of body weight (King, 2006). We hypothesized that
ERa in the VMH is required to mediate the estrogenic effects
on energy balance. Because SF1, a transcription factor, is
expressed exclusively in the VMH within the brain (Ikeda et al.,
1995), we used a SF1-Cre transgenic mice (line 7) (Dhillonc.
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CNS ERa Controls Energy Balance and Fertilityet al., 2006) to generate mice lacking ERa in the VMH (ERalox/lox/
SF1-Cre). In control (SF1-Cre/rosa26GFP) mice, 48.3% ± 5.7%
of ERa neurons in the VMH coexpress SF1, and 12.0% ± 1.9%
of SF1 neurons express ERa. In ERalox/lox/SF1-Cre/rosa26GFP
mice, the majority of ERa was selectively deleted from the
VMH SF1 neurons (Figure S2). Importantly, we found that the
numbers of SF1neurons in ERalox/lox/SF1-Cre/rosa26GFP mice
and in control mice were comparable (Figure S2), suggesting
that deletion of ERa did not cause loss of the SF1 neuronal pop-
ulation in the VMH.
Increased Body Weight, Adiposity, and Visceral
Fat Distribution
When fed on regular chow, male ERalox/lox/SF1-Cre and control
(ERalox/lox) littermates had comparable body weight and body
composition (Figures 2A and 2B). The chow-fed ERalox/lox/
SF1-Cre females had modest but significant increases in body
weight (Figure 2C) and had increases in both fat mass and
lean mass (Figure 2D). When fed with high-fat diet (HFD), male
ERalox/lox/SF1-Cre and control mice showed comparable body
weight (Figure 2E) and fat/lean mass (Figure 2F). On the other
hand, HFD-fed ERalox/lox/SF1-Cre females had significant
increases in body weight compared to control mice (Figure 2G),
which were reflected by increases in both fat mass and lean
mass (Figure 2H). Collectively, these results indicate that ERa
expressed by SF1 cells is required to maintain body weight
homeostasis in females, but not in males.
ERalox/lox/SF1-Cre females displayed significantly higher
visceral fat distribution but lower subcutaneous fat distribution
than controls (Figure 2I). Interestingly, 30% of adult ERalox/lox/
SF1-Cre females had a massive accumulation of gonadal
adipose tissue as demonstrated by appearance (Figure 2J) and
weight (Figure 2K). Although it is unclear why the gonadal fat
pads in subsets of mutant mice form this peculiar shape, this
phenomenon is consistent with the abdominal obese phenotype.
Given that increased visceral fat is commonly associated with
impaired glucose homeostasis (Lafontan and Girard, 2008), we
performed glucose tolerance tests and found that ERalox/lox/
SF1-Cre females were glucose intolerant (Figure 2L). Collec-
tively, these results indicate that ERa in SF1 neurons is required
for the regulation of fat distribution. Loss of ERa in SF1 neurons
leads to abdominal obesity, which subsequently causes glucose
dysregulation.
We further characterized the white adipose tissue (WAT) in
these mutant females. We found that the average adipocyte
size of gonadal WAT was larger in ERalox/lox/SF1-Cre mice (Fig-
ures 2M and 2N). Importantly, compared to controls, ERalox/lox/
SF1-Cre females stored more energy in the gonadal WAT,
demonstrated by significantly increased triglyceride content
(normalized by fat weight) (Figure 2P). Consistently, mRNA levels
of genes promoting lipogenesis and triglyceride storage,
including stearoyl-CoA desaturase-1 (SCD1), lipoprotein lipase
(LPL), and acetyl-CoA carboxylase a (ACCa), were significantly
elevated in gonadal WAT of ERalox/lox/SF1-Cre females (Fig-
ure 2Q). These findings indicate that ERa in SF1 neurons is
required for the regulation of energy partitioning in the gonadal
WAT. On the other hand, the inguinal WAT of ERalox/lox/SF1-
Cre mice and controls had comparable adipocyte size (Figures
2M and 2O), triglyceride content (Figure 2P), and gene expres-
sion profile (Figure 2Q). No significant difference was observedCellin the expression of fatty acid synthase (FAS), ERa, and ERb in
all the fat pads (Figure 2Q).
Decreased Energy Expenditure
The increased body weight and adiposity in ERalox/lox/SF1-Cre
females was not due to differences in energy intake, because
young or adult female ERalox/lox/SF1-Cre and control mice
consumed comparable levels of calories (Figure 3A). In contrast,
ERalox/lox/SF1-Cre females were hypometabolic, as demon-
strated by significant decreases in heat production (Figure 3B).
Components of total energy expenditure include energy required
for physical activities, basal metabolism, and diet-induced
thermogenesis (Castaneda et al., 2005). In particular, ERalox/lox/
SF1-Cre females showed normal ambulatory movements and
rearing activities (Figures 3C and 3D), indicating that ERa in
SF1 neurons is not required to regulate physical activity. We
further assessed the basal metabolic rate by measuring the
minimal heat production during the light cycle (Kaiyala et al.,
2010) and found that ERalox/lox/SF1-Cre females had significant
reductions in basal metabolic rate (Figure 3E). To assess diet-
induced thermogenesis, we monitored energy expenditure in
response to a fasting-refeeding paradigm. The increased heat
production in ERalox/lox/SF1-Cre mice was significantly reduced
(Figures 3F and 3G). Thus, our results suggest that ERa ex-
pressed by VMHSF1 neurons is required to regulate basal meta-
bolic rate and to mediate appropriate thermogenic responses to
feeding.
Impaired BAT Thermogenesis
Brown adipose tissue (BAT) plays crucial roles in mediating ther-
mogenesis (Dulloo, 2002). Although the weight of BAT was not
different between genotypes (ERalox/lox, 86.67 ± 7.68 mg versus
ERalox/lox/SF1-Cre, 97.86 ± 7.16mg, p > 0.05, n = 12 or 15/geno-
type), histological analyses revealed a large amount of lipid
deposition in the ERalox/lox/SF1-Cre BAT (Figure 3H). Consis-
tently, UCP1 mRNA levels in the ERalox/lox/SF1-Cre BAT were
significantly reduced (Figure 3I). In addition, mRNA levels of
peroxisome proliferator-activated receptor g (PPARg), PPARg
coactivator-1a (PGC-1a), and b3 adrenergic receptor, factors
known to stimulate UCP1 expression (Seale et al., 2007), were
significantly lower in ERalox/lox/SF1-Cre BAT (Figure 3I). The
levels of PRDM16 and ERa in BAT were not altered (Figure 3I).
Taken together, these findings suggest that reduced ERa signals
in VMH SF1 neurons led to a reduction in thermogenic functions
of BAT by suppressing UCP1 expression.
Decreased Sympathetic Outflow
ERalox/lox/SF1-Cre females had significantly lower plasma
norepinephrine levels than controls; plasma epinephrine levels
were not significantly different (Figure 3J). These findings
suggest that ERa in VMH SF1 neurons is required to maintain
normal central sympathetic outflow to the peripheral tissues.
The decreased sympathetic tone in ERalox/lox/SF1-Cre mice
could contribute to decreased BAT thermogenesis and the
increased lipid accumulation in gonadal WAT.
Decreased Expression of Leptin Receptors
Messenger RNA of leptin receptors was significantly reduced
in the VMH of ERalox/lox/SF1-Cre females (Figure 3K). These
findings support the possibility that ERa signals in SF1 neurons
are required to maintain normal leptin sensitivity by regulating
transcription of leptin receptors. No significant changes were
found in the mRNA levels of SF1, ERb, thyroid hormoneMetabolism 14, 453–465, October 5, 2011 ª2011 Elsevier Inc. 455
Figure 2. ERa Expressed by SF1 Neurons Regulates Body Weight and Fat Distribution
(A) Weekly body weight in male mice weaned on regular chow (n = 6 or 12/genotype).
(B) Body composition in 11-week-old male mice fed with regular chow (n = 6 or 12/genotype).
(C) Weekly body weight in female mice weaned on regular chow (n = 22 or 25/genotype).
(D) Body composition in 11-week- old female mice fed with regular chow (n = 22 or 25/genotype).
(E) Weekly body weight in male mice weaned on HFD (n = 11 or 21/genotype).
(F) Body composition in 12-week-old male mice fed with HFD (n = 11 or 21/genotype).
(G) Weekly body weight in female mice weaned on HFD (n = 10 or 15/genotype).
(H) Body composition in 8-week-old female mice fed with HFD (n = 10 or 15/genotype).
Cell Metabolism
CNS ERa Controls Energy Balance and Fertility
456 Cell Metabolism 14, 453–465, October 5, 2011 ª2011 Elsevier Inc.
Figure 3. ERa Expressed by SF1 Neurons Regulates Energy Expenditure
(A) Daily food intake in 5-week-old femalemice fedwith regular chow (n = 7 or 23/genotype), 11-week-old femalemice fedwith regular chow (n = 9/genotype), and
12-week-old female mice fed with HFD (n = 12/genotype).
(B–E) Chow-fed female mice were acclimated to the TSE metabolic chambers (n = 11 or 12/genotype). Shown are average heat production (B), ambulatory
movements (C), and rearing activities (D) during 24 hr, 12 hr dark cycle and 12 hr light cycle, and basal metabolism (E). Note that mice used in (B)–(E) were
20-week-old littermates and had comparable body weight (ERalox/lox, 20.26 ± 0.47 versus ERalox/lox/SF1-Cre: 21.31 ± 0.53, p > 0.05), fat mass (ERalox/lox, 3.37 ±
0.26 versus ERalox/lox/SF1-Cre, 4.10 ± 0.45, p > 0.05), and lean mass (ERalox/lox, 15.45 ± 0.45 versus ERalox/lox/SF1-Cre, 15.97 ± 0.34, p > 0.05).
(F and G) HFD-fed female mice were acclimated to the TSE metabolic chambers. HFD was removed from the TSE metabolic chambers for 24 hr, followed by
refeeding for 24 hr. Temporal responses in heat production (F) of female mice during fasting and HFD refeeding were monitored. (G) Increases in heat production
after HFD refeeding were calculated by subtracting heat production during 24 hr fasting from heat production during 24 hr refeeding. Note that mice used in (F)
and (G) were 12-week-old littermates and had comparable body weight (ERalox/lox, 20.75 ± 0.39 versus ERalox/lox/SF1-Cre, 21.05 ± 0.65, p > 0.05) but different fat
mass (ERalox/lox, 3.55 ± 0.19 versus ERalox/lox/SF1-Cre, 4.23 ± 0.22, p < 0.05) and lean mass (ERalox/lox, 13.55 ± 0.32 versus ERalox/lox/SF1-Cre, 14.77 ± 0.34,
p < 0.05).
(H) Representative photomicrographs of H&E staining of BAT from 16-week-old HFD-fed females.
(I) Messenger RNA levels in BAT from 16-week-old HFD-fed females (n = 6/genotype).
(J) Plasma norepinephrine and epinephrine in chow-fed females (n = 6/genotype).
(K) Messenger RNA levels in microdissected VMH from 16-week-old HFD-fed females (n = 6/genotype). Data are presented as mean ±SEM, and *p < 0.05,
**p < 0.01, and ***p < 0.001 between ERalox/lox/SF1-Cre mice and ERalox/lox mice.
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CNS ERa Controls Energy Balance and Fertilityreceptor-a (THRa), and growth hormone secretagogue receptor
(GHSR, ghrelin receptors) in the VMH of ERalox/lox/SF1-Cre
females (Figure 3K).
Responses in the Pituitary, Adrenal Gland, and Gonads
In addition to the VMH in the brain, SF1 cells are also found in the
pituitary, adrenal gland, and gonads (Zhao et al., 2001). There-(I) Relative fat distribution in the visceral and subcutaneous depots in 8-week-old
(J) Photographs of two ERalox/lox/SF1-Cre female mice (the first and second from
carcass of one ERalox/lox/SF1-Cre female (the fourth from the left; note that the a
(K) Weight of gonadal WAT in 6-week-old female mice fed with regular chow (n =
(L) Glucose tolerance test in 10-week-old chow-fed female mice (i.p. 1 g/kg gluc
(M) Representative photomicrographs of H&E staining of gonadal WAT and ingu
(N and O) Cell size in gonadal WAT (N) and inguinal WAT (O) from 16-week-old H
(P) Triglyceride content in gonadal WAT and inguinal WAT from 16-week-old HF
(Q) Messenger RNA levels inWAT from 16-week-old HFD-fed females (n = 6/geno
ERalox/lox/SF1-Cre mice and ERalox/lox mice.
Cellfore, ERa may be deleted in these endocrine organs, which
may potentially confound the metabolic phenotypes. We found
that ERa mRNA levels were comparable in these organs from
the two genotypes (Figure S3A). These results suggest that
ERamay not be expressed in SF1 cells in these peripheral organs
inwild-typemice, and therefore SF1-Cre-induced recombinationfemale mice fed with HFD (n = 5/genotype).
the left) and one ERalox/lox female (the third from the left); the photograph of the
bdominal wall of the mouse was intact).
6 or 9/genotype).
ose, n = 8 or 11/genotype).
inal WAT from 16-week-old HFD-fed females.
FD-fed females (n = 3 or 4/genotype).
D-fed ERalox/lox and ERalox/lox/SF1-Cre females (n = 6/genotype).
type). Data are presented asmean ±SEM, and *p < 0.05 and **p < 0.01 between
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Figure 4. Deletion of ERa in POMC Neurons Leads to Increased Body Weight and Lean Mass
(A) Weekly body weight in male mice weaned on regular chow (n = 33 or 34/genotype).
(B) Weekly body weight in female mice weaned on regular chow (n = 25 or 32/genotype).
(C) Body composition in 11-week-old female mice fed with regular chow (n = 25 or 32/genotype).
(D) Relative fat distribution in the visceral and subcutaneous depots in 18-week-old female mice fed with regular chow (n = 5/genotype).
(E) Weight of gonadal WAT in 6-week-old female mice fed with regular chow (n = 8 or 9/genotype).
(F) Representative photomicrographs of H&E staining of gonadal WAT and inguinal WAT from 5-month-old chow-fed females.
(G and H) Cell size in gonadal WAT (G) and inguinal WAT (h) from 5-month-old chow-fed females (n = 3/genotype). Data are presented as mean ±SEM, and
*p < 0.05, **p < 0.01, and ***p < 0.001 between ERalox/lox/POMC-Cre mice and ERalox/lox mice.
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these peripheral SF1 cells, if any, may be compensated by
elevated ERa expressed by non-SF1 cells in the same organs.
We further examined the impact of the possible ERa deletion
on the functions of these organs. We found that there were no
significant changes in the plasma estradiol-17b, corticosterone,
T3/T4, progesterone, FSH, or LH (Table S1). Nomajor abnormal-
itieswere observed in themorphology of the pituitary and adrenal
gland (Figure S3B). However, in ERalox/lox/SF1-Cre mice, their
ovaries showed an increased number of antral follicles and lack
of corpus luteum (Figure S3B), consistent with our findings that
ERalox/lox/SF1-Cre females were infertile (data not shown).
Nevertheless, because the hormones secreted from the pituitary,
adrenal gland, and ovary were not significantly altered, it is
unlikely that the metabolic phenotypes outlined above are due
to the possible deletion of ERa in these peripheral organs,
although this possibility cannot be fully excluded.
Loss of ERa in POMC Neurons Directly Affects Feeding
and Negative Feedback
Validation
POMC neurons secrete a-melanocyte-stimulating hormone
(a-MSH) to reduce food intake and increase energy expenditure
(Morton et al., 2006). Estrogens activate POMC neurons (Gao
et al., 2007; Malyala et al., 2008). However, the physiological
significance of ERa expressed by POMC neurons has not been
directly tested. We crossed ERalox/lox mice to the POMC-Cre
transgenic mice to generate mice lacking ERa in POMC neurons
(ERalox/lox/POMC-Cre). In control (POMC-Cre/rosa26GFP) mice,458 Cell Metabolism 14, 453–465, October 5, 2011 ª2011 Elsevier In21.5% ± 2.5% of POMC neurons in the ARH and 20.9% ± 4.8%
of POMC neurons in the NTS coexpressed ERa (Figure S4). In
ERalox/lox/POMC-Cre/rosa26GFP mice, only 1.9% ± 0.4% of
POMC neurons in the ARH and none in the NTS coexpressed
ERa, confirming that the majority of ERa was selectively deleted
from POMC neurons (Figure S4). Importantly, deletion of ERa
from POMC neurons did not cause loss of POMC neurons
(Figure S4).
Increased Body Weight
Male ERalox/lox/POMC-Cre and control (ERalox/lox) littermates
showed comparable body weight (Figure 4A). On the other
hand, ERalox/lox/POMC-Cre females had significant increases
in body weight (Figure 4B), mainly reflected by increases in
lean mass (Figure 4C). No significant differences were observed
in the visceral/subcutaneous fat distribution (Figure 4D), the
weight of gonadal fat pads (Figure 4E), and the adipocyte
size in gonadal and inguinal WAT (Figures 4F–4H) between the
ERalox/lox/POMC-Cre females and controls.
Hyperphagia and Blunted Anorexigenic Responses
to Leptin
ERalox/lox/POMC-Cre females displayed a chronic hyperphagia.
This is demonstrated by significant increases in food intake in
chow-fed ERalox/lox/POMC-Cre females at 4 and 6 months of
age (Figure 5A). When normalized by lean mass, food intake
was significantly increased at 6 months (Figure 5B). We further
examined the effects of anorexigenic hormones in these
females. While leptin (5 mg/kg, i.p.) significantly reduced food
intake in controls, these anorexigenic effects were blunted in
ERalox/lox/POMC-Cre females (Figure 5C). In contrast, anorexiac.
Figure 5. Deletion of ERa in POMC Neurons Leads to Hyperphagic and Hypermetabolic Phenotypes
(A) Daily food intake in 4-month-old and 6-month-old female mice fed with regular chow (n = 12 or 13/genotype).
(B) The same food intake data in (A) presented as daily food intake normalized by lean mass.
(C) Effects of i.p. injections of leptin (5 mg/kg) on food intake in 12-week-old chow-fed female mice (n = 8/group).
(D) Effects of i.p. injections of MTII (1 mg/kg) on food intake in 16-week-old chow-fed female mice (n = 8/group).
(E–I) HFD-fed female mice (n = 10 or 13/genotype) were acclimated to the TSEmetabolic chambers. Average heat production (E), ambulatory movements (F), and
rearing activities (G) during 24 hr, 12 hr dark cycle and 12 hr light cycle, were measured at fed condition. (H and I) HFD was removed from the TSE metabolic
chambers for 24 hr, and average heat production (H) during 24 hr, 12 hr dark cycle and 12 hr light cycle, was measured at fasted condition. (I) Body weight loss
induced by 24 hr fasting was measured. Note that mice used in (E)–(I) were 20-week-old littermates and had comparable body weight (ERalox/lox, 25.14 ± 1.16
versus ERalox/lox/POMC-Cre, 25.12 ± 0.95, p > 0.05), fat mass (ERalox/lox, 8.84 ± 0.13 versus ERalox/lox/POMC-Cre, 8.80 ± 0.11, p > 0.05), and lean mass
(ERalox/lox, 14.28 ± 0.27 versus ERalox/lox/POMC-Cre, 14.72 ± 0.22, p > 0.05).
(J) Plasma norepinephrine and epinephrine in chow-fed females (n = 6/genotype). Data are presented as mean ±SEM, and *p < 0.05 and **p < 0.01 between
ERalox/lox/POMC-Cre mice and ERalox/lox mice.
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in ERalox/lox/POMC-Cre and controls (Figure 5D). Collectively,
these findings demonstrated that ERa in POMC neurons is
required to maintain normal feeding behavior, at least partly
through interacting with the anorexigenic leptin signals.
Increased Energy Expenditure, Sympathetic Outflow,
and Plasma Estradiol-17b
Unexpectedly, ad libitum ERalox/lox/POMC-Cre females showed
increased heat production (Figure 5E). In addition, the ambula-
torymovements during the dark cycle were significantly elevated
in the ERalox/lox/POMC-Cre females (Figure 5F), which may at
least partly contribute to the increased energy expenditure.
The rearing activities were comparable between the two geno-
types (Figure 5G). To further confirm the unexpected hypermet-
abolic phenotypes, we examined the energy expenditure
during fasting. Consistent with results from ad libitum mice,
ERalox/lox/POMC-Cre mice showed increased heat production
during 24 hr fasting (Figure 5H), which led to a significantly
greater weight loss (Figure 5I). Interestingly, ERalox/lox/POMC-
Cre females had significantly higher plasma norepinephrineCellthan control mice, while plasma epinephrine levels were compa-
rable (Figure 5J). The elevated sympathetic tone may be the
underlying mechanisms for elevated metabolism seen in these
ERalox/lox/POMC-Cre mice.
Although we cannot fully exclude the possibility that the
increases in sympathetic outflow and energy expenditure in
ERalox/lox/POMC-Cre females are directly due to ERa deletion
from POMC neurons, it is more likely that these phenotypes
may result from compensatory actions of ERa in other CNS
sites. Supporting this notion, we found that ERalox/lox/POMC-
Cre females have significantly higher plasma estradiol-17b
levels (Figure 6A). Presumably, the elevated estradiol-17b
would act on other CNS ERa sites (including SF1 neurons) to
increase sympathetic outflow, energy expenditure, and physical
activity.
Impaired Negative Feedback and Fertility
Plasma progesterone in ERalox/lox/POMC-Cre females trended
to increase but failed to reach statistical significance (Figure 6B).
Although the basal FSH and LH levels in gonad intact females
were not significantly altered (Table S2), the estrogen-inducedMetabolism 14, 453–465, October 5, 2011 ª2011 Elsevier Inc. 459
Figure 6. Deletion of ERa in POMC Neurons Leads to Fertility Phenotypes
(A and B) Plasma estradiol-17b (A) and progesterone (B) at diestrus in 6-month-old female mice fed with HFD (n = 6 or 8/genotype).
(C and D) Relative mRNA levels of FSHb (C) or LHb (D) in the pituitary measured 4 weeks after receiving ovriectomy plus estradiol-17b replacement (0.5 mg/day/
mouse, OVX+E) or plus vehicle (OVX+V) (n = 6/group).
(E and F) Plasma FSH (E) or LH (F) measured in mice described in (C) and (D).
(G) Length of diestrus, proestrus, and estrus relative to the entire etrus cycles (n = 8 or 17/genotype).
(H) Percentage of mice that successfully delivered pups (n = 8 or 20/genotype).
(I) Averaged time period between mating day and birth day of pups (n = 8 or 6/genotype).
(J) Averaged litter size (n = 8 or 6/genotype). Note that only mice that successfully delivered pups in (H) were included in the analyses in (I) and (J).
(K) RelativemRNA levels in the hypothalamus from 16-week-old chow-fed females (n = 6/genotype). Data are presented asmean ±SEM, and *p < 0.05, **p < 0.01,
and ***p < 0.001 between ERalox/lox/POMC-Cre mice and ERalox/lox mice.
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Cre females. Specifically, estradiol-17b replacement in OVX
control females significantly suppressed expression of FSH
and LH subunits in the pituitary, whereas these negative feed-
back effects were blunted in ERalox/lox/POMC-Cre females (Fig-
ures 6C and 6D). Similar patterns were also observed in plasma
FSH and LH (Figures 6E and 6F). These results suggest that
ERa in POMC neurons is required to mediate the negative feed-
back regulation. Of note, the plasma FSH/LH levels after OVX
appeared to be lower in ERalox/lox/POMC-Cre compared to
control mice (Figures 6E and 6F), while the pituitary mRNA levels
of FSH/LH subunits in the same mice were comparable (Figures
6C and 6D). This discrepancy suggests that the secretion of
FSH/LH or the stability/degradation of plasma FSH/LH may be
differently regulated in the OVX ERalox/lox/POMC-Cre mice.
In addition, we found that the gonad-intact ERalox/lox/POMC-
Cre females had abnormal estrous cycles. The length of the es-
trous phase was significantly reduced, while the diestrus phase
trended to be elongated in ERalox/lox/POMC-Cre mice (Fig-
ure 6G). No differences were observed in the length of the proes-
trus phase (Figure 6G). Further, female ERalox/lox/POMC-Cre
mice had impaired reproductive capacity. In particular, only460 Cell Metabolism 14, 453–465, October 5, 2011 ª2011 Elsevier In30% of ERalox/lox/POMC-Cre females (6 out of 20) were able to
conceive and deliver, while 100% of the age-matched control
females gave birth (Figure 6H). In addition, it took significantly
longer for the six ERalox/lox/POMC-Cre dams to conceive than
the controls (Figure 6I). The average litter size from these dams
was significantly reduced (Figure 6J). No major abnormalities
were observed in the morphology of ovaries from ERalox/lox/
POMC-Cre females (Figure S5C). Collectively, these findings
indicate that ERa in POMC neurons is required to maintain
normal estrous cyclicity and female fertility.
Expression of Hypothalamic Genes
In an attempt to further characterize the effects of estrogen/
ERa on POMC neurons, we examined the gene expression
profile in the hypothalamus of ERalox/lox/POMC-Cre females.
However, there was no significant difference in the expression
of POMC, AgRP, NPY, CART, leptin receptors, SF1, GnRH,
Kiss1, and GPR54 between ERalox/lox/POMC-Cre females and
controls (Figure 6K).
Responses in Pituitary Functions
In addition to the POMCneurons in the brain, POMC (ACTH) cells
also exist in the pituitary. We found that ERa mRNA was signifi-
cantly reduced in the ERalox/lox/POMC-Cre pituitary (Figure S5A),c.
Figure 7. Deletion of ERa in Both SF1 and POMC Neurons Produces Hyperphagia and Decreased Energy Expenditure
(A) Weekly body weight in male mice weaned on regular chow (n = 6 or 15/genotype).
(B) Body composition in 12-week-old male mice fed with regular chow (n = 6 or 15/genotype).
(C) Weekly body weight in female mice weaned on regular chow (n = 11 or 39/genotype).
(D) Body composition in 12-week-old female mice fed with regular chow (n = 11 or 39/genotype).
(E) Weight of gonadal WAT in 6-week-old female mice fed with regular chow (n = 7 or 9/genotype).
(F) Photograph of an ERalox/lox/SF1-Cre/POMC-Cre female mouse at the age of 6 weeks.
(G) Appearance rate of abdominal obesity (defined by obvious abnormal expansion of the lower abdominal obesity).
(H) Daily food intake was measured in 6-week-old female mice fed with regular chow (n = 6 or 17/genotype).
(I–K)Chow-fed femalemice (n = 6 or 17/genotype)were acclimated to the TSEmetabolic chambers, and averageheat production (I), ambulatorymovement (J), and
rearing activity (K) during 24 hr, 12 hr dark cycle and 12 hr light cycle, were measured. Note that mice used in (H)–(K) were 6-week-old littermates and had com-
parable body weight (ERalox/lox, 16.63 ± 1.01 versus ERalox/lox/SF1-Cre/POMC-Cre, 18.09 ± 0.51, p > 0.05) and fat mass (ERalox/lox, 2.15 ± 0.37 versus ERalox/lox/
SF1-Cre/POMC-Cre, 1.88 ± 0.26, p < 0.01) but different lean mass (ERalox/lox, 12.33 ± 0.35 versus ERalox/lox/SF1-Cre/POMC-Cre, 13.69 ± 0.22, p < 0.01).
(L) Plasma norepinephrine and epinephrine in chow-fed females (n = 4/genotype, 6 weeks of age). Data are presented as mean ±SEM, and *p < 0.05, **p < 0.01,
and ***p < 0.001 between ERalox/lox/SF1-Cre/POMC-Cre mice and ERalox/lox mice.
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cells. However, we did not find any significant changes in
POMC (ACTH) expression in the pituitary (Figure S5B). In addi-
tion, plasma levels of corticosterone at either basal or stressed
conditions were comparable between ERalox/lox/POMC-Cre
females and controls (Table S2). Morphologic analysis did not
reveal any alterations in the pituitary (Figure S5B). In addition,
we did not detect any significant changes in plasma T3/T4 levels
(Table S2). Therefore, it is unlikely that the metabolic and repro-
ductive phenotypes observed in ERalox/lox/POMC-Cre females
are due to loss of ERa from the pituitary ACTH cells, although
we cannot fully rule out this possibility.
Double Deletion of ERa from SF1/POMC Neurons
Affects Feeding, Energy Expenditure, and Fat
Distribution
Our data indicated that ERa in SF1 neurons is required to regu-
late energy expenditure and fat distribution, while ERa in POMCCellneurons is required for the regulation of feeding. To further
confirm this model, we generated mice lacking ERa in both
SF1 and POMC neurons (ERalox/lox/SF1-Cre/POMC-Cre) and
the control (ERalox/lox) littermates.
Chow-fed male ERalox/lox/SF1-Cre/POMC-Cre mice and
controls showed comparable body weight and body composi-
tion (Figures 7A and 7B). Female ERalox/lox/SF1-Cre/POMC-
Cre mice had significantly increased body weight (Figure 7C),
whichwasmainly reflected by increases in leanmass (Figure 7D).
Although the whole-body fat mass was not different (Figure 7D),
the average weight of gonadal fat was significantly increased in
ERalox/lox/SF1-Cre/POMC-Cre females (Figure 7E). Similar to
ERalox/lox/SF1-Cre females, subsets of ERalox/lox/SF1-Cre/
POMC-Cre females displayed the massive gonadal fat expan-
sion (Figure 7F). While 30% of ERalox/lox/SF1-Cre females devel-
oped this phenotype during adulthood (2–3 months), 50% of
ERalox/lox/SF1-Cre/POMC-Cre females developed the same
phenotype at earlier ages (as early as 2weeks of age) (Figure 7G).Metabolism 14, 453–465, October 5, 2011 ª2011 Elsevier Inc. 461
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hyperphagic (Figure 7H) but also showed decreased heat
production (Figure 7I). No significant difference was observed
in ambulatory movements and rearing activities in female mice
(Figures 7J and 7K). Finally, ERalox/lox/SF1-Cre/POMC-Cre
females had significantly lower plasma norepinephrine levels
than controls; epinephrine levels were not significantly different
(Figure 7L). Collectively, these findings indicate that ERa ex-
pressed by SF1 and POMC neurons provides the coordinated
control of food intake, energy expenditure, and fat distribution.
Cre Transgenes Do Not Affect Body Weight
To rule out the possibility that the Cre transgenes used in the
present study may have independently contributed to the meta-
bolic phenotypes, we generated parallel cohorts of transgenic
mice carrying only the Nestin-Cre, SF1-Cre, or POMC-Cre trans-
gene and their respective wild-type littermates. Thesemice were
produced at the same genetic background as those conditional
knockout mice. No significant change in body weight was
observed in these transgenic Cre mice (Figure S6).
DISCUSSION
Genetic Segregation of ERa Functions in the Brain
The estrogen/ERa system is known to regulate food intake,
energy expenditure, physical activity (Gao et al., 2007), and fat
distribution (Heine et al., 2000). ERa-expressing cells mediating
these estrogenic effects were not identified prior to our study.
The phenotypic comparison in the four mousemodels we gener-
ated provides evidence to support a segregation model in which
ERa is expressed by distinct hypothalamic neurons and medi-
ates different functions of estrogens in the context of energy
homeostasis.
Mice lacking ERa in the CNS have hyperphagia and decreased
energy expenditure. These results indicate that CNS ERa is
required to suppress food intake and increase energy expendi-
ture. The anorexigenic effects of estrogens are further pin-
pointed to be mediated by ERa-positive POMC neurons, as
mice lacking ERa in POMC neurons or in both POMC and SF1
neurons develop hyperphagia, while deletion of ERa only in
SF1 neurons does not affect feeding.
We identify ERa-positive SF1 neurons as the key site where
estrogens act to stimulate energy expenditure, since deletion
of ERa in SF1 neurons produces hypometabolic phenotypes.
The increased energy expenditure seen in ERalox/lox/POMC-
Cre mice is unexpected, as estrogens are known to activate
POMC neurons (Malyala et al., 2008), and activation of POMC
neurons would increase energy expenditure (Morton et al.,
2006). The fact that ERalox/lox/POMC-Cre mice have elevated
estradiol-17b levels suggests that the increased energy expendi-
ture may result from compensatory estrogenic actions in other
ER sites. Since mice lacking ERa in the CNS show decreased
energy expenditure despite the elevated estradiol-17b levels,
these ‘‘compensatory’’ estrogen signals must be neuronal in
origin. In addition, decreased energy expenditure in ERalox/lox/
SF1-Cre/POMC-Cre mice further demonstrates that ERa-posi-
tive SF1 neurons are at least one site where elevated estradiol-
17b acts to stimulate energy expenditure in ERalox/lox/POMC-
Cre mice.462 Cell Metabolism 14, 453–465, October 5, 2011 ª2011 Elsevier InEstrogen/ERa signals also suppress fat accumulation in the
visceral adipose depot (Heine et al., 2000; Rogers et al., 2009).
We show that CNS deletion of ERa leads to increased visceral
fat distribution. Further, mice lacking ERa in SF1 neurons or in
both SF1 and POMC neurons show increased visceral fat distri-
bution, whereas deletion of ERa in POMC neurons alone does
not influence fat distribution. Therefore, these findings indicate
that ERa in SF1 neurons is required tomediate estrogenic effects
on fat distribution.
Collectively, our results indicate that estrogenic effects on
food intake, energy expenditure, and fat distribution are medi-
ated by segregated hypothalamic ERa populations. Thus, ERa
in SF1 neurons is required to maintain normal energy expendi-
ture and fat distribution, while ERa in POMC neurons regulates
feeding.
Notably, CNS deletion of ERa leads to hypoactivity, indicating
that CNS ERa is required to stimulate physical activity. However,
this phenotype is not observed in mice lacking ERa in SF1
neurons, in POMC neurons, or in both, which implies that other
CNS neurons expressing ERa may be responsible for these
effects. Of note, animals with ERa knocked down in the VMH
display decreased physical activity (Musatov et al., 2007).
Together with our observations, these findings suggest that
non-SF1 neurons in the VMH may mediate estrogenic actions
to regulate physical activity.
ERa mutations in male mice and men cause obesity (Heine
et al., 2000; Smith et al., 1994). Consistently, we show that
CNS deletion of ERa also promotes body weight gain in males.
These findings highlight the physiological relevance of ERa in
male brains in the regulation of energy balance. Notably, deletion
of ERa in SF1 neurons, POMC neurons, or both does not affect
body weight in male mice. Collectively, these findings indicate
that other ERa sites in male brains contribute to the regulation
of energy balance. Further efforts are warranted to unravel these
unknown ERa sites in male brains.
Estrogenic Actions in VMH SF1 Neurons
The major metabolic phenotypes in mice lacking ERa in SF1
neurons include decreased energy expenditure (e.g., BAT ther-
mogenesis) and increased lipid accumulation in gonadal WAT.
Both these deficits could be attributed to decreased sympa-
thetic tone (lower norepinephrine). Consistently, electric stimula-
tion of the VMH increases sympathetic inputs to BAT and
enhances thermogenesis (Saito et al., 1987). Lipid metabolism
in gonadal WAT is also regulated by the sympathetic nervous
system. For example, increased lipolysis in gonadal WAT is
associated with elevated sympathetic inputs (Plum et al.,
2007), while the expanded gonadal WAT is found to have
decreased sympathetic inputs (Ramadori et al., 2010). Collec-
tively, these findings support a model in which estrogens act
on ERa in VMH SF1 neurons to increase central sympathetic
outflow, which leads to increased BAT thermogenesis and
inhibits lipid storage in gonadal WAT.
The intracellular mechanisms by which estrogen/ERa regulate
SF1 neurons are not fully understood. Park et al. reported
that estrogens activate the rapid PI3K-Akt pathway in the VMH
via an ERa-dependent mechanism (Park et al., 2011). Remark-
ably, restoration of ERa-associated rapid signaling pathways
(including the PI3K-Akt pathway) at the global ERa nullc.
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addition, we have previously shown that selective inhibition of
PI3K in SF1 neurons leads to obesity (Xu et al., 2010). Collec-
tively, these findings suggest that the PI3K pathway (and/
or other rapid signaling pathways) in SF1 neurons may mediate
antiobesity effects of estrogens.
Alternatively, ERamay regulate SF1 neurons as a transcription
factor. We show that mice lacking ERa in SF1 neurons have
decreased expression of leptin receptors in the VMH. Consis-
tent with a possible role of estrogen/ERa on expression of
leptin receptors, these two receptors are found to be coex-
pressed by VMH neurons (Diano et al., 1998), and an estrogen
response element (ERE) was found in the promoter region of
the leptin receptor gene (Lindell et al., 2001). In addition, selec-
tive deletion of leptin receptors in SF1 neurons produces
similar obese phenotypes (Dhillon et al., 2006). Collectively,
these data suggest that ERa in SF1 neurons may regulate
energy homeostasis, at least partly, by modulating leptin sensi-
tivity in the VMH.
Estrogenic Actions in POMC Neurons
Mice lacking ERa in POMC neurons develop hyperphagia, indi-
cating that ERa signals in POMC neurons are physiologically
relevant in the regulation of feeding. This regulation may be
mediated by estrogenic actions on POMC neural activity, as
estrogens have been shown to activate POMC neurons (Gao
et al., 2007; Malyala et al., 2008). Alternatively, estrogens may
regulate feeding partly via sensitizing responses to other anorex-
igenic hormones, such as leptin. We previously demonstrated
that estrogens potentiate the anorexigenic effects of leptin
(Clegg et al., 2006). We now extend those findings to demon-
strate that the effects of leptin on food intake are blunted in
mice lacking ERa in POMC neurons. Importantly, the efficacy
of MTII’s anorexia is not affected in these mice, suggesting
that the impairments of estrogenic actions are constrained to
the POMC neurons. Recent evidence indicates that estrogens,
similar to leptin, induce STAT3 phosphorylation in the hypothal-
amus, and that the antiobesity effects of estrogens are abolished
in mice lacking STAT3 in the brain (Gao et al., 2007). Therefore, it
is possible that estrogens may initiate signals in POMC neurons
which ultimately converge on the leptin-induced pSTAT pathway
to regulate food intake.
While the majority of POMC neurons reside in the ARH of the
hypothalamus, a small subset of POMC neurons are also found
in the NTS of the brain stem, which are implicated in the regula-
tion of satiety (Fan et al., 2004). In addition, estrogens increase
c-fos immunoreactivity in the NTS via ERa-mediated mecha-
nisms (Asarian and Geary, 2007). Notably, our POMC-Cre
induced efficient ERa deletion in the NTS, as well as in the
ARH. Therefore, these findings support an alternative model in
which estrogens may regulate food intake at least partly by
acting on ERa expressed by NTS POMC neurons.
Hypothalamic ERa and Reproduction
ERalox/lox/SF1-Cre females develop infertility likely due to anov-
ulation (the lack of ovarian corpus luteum). An important question
remains as to whether this ovarian phenotype results from loss
of ERa in VMH SF1 neurons or from loss of ERa in ovarian SF1
cells. Although we did not find significant reduction of ERaCellmRNA in the ovary of ERalox/lox/SF1-Cre mice, we could not fully
exclude the possibility that ERa is deleted in ovarian SF1 cells.
On the other hand, it is interesting to note that our ERalox/lox/
SF1-Cre female mice recapitulate the ovarian phenotypes
(numerous antral follicles and lack of corpus luteum) seen in
ERalox/lox/CAMKII-Cre mice, a brain-specific ERa knockout
model (Wintermantel et al., 2006). Therefore, it is possible that
the ovarian phenotypes are caused by loss of ERa in SF1
neurons in the brain. Supporting this notion, genetic ablation
of SF1 neurons in the brain leads to decreased or reduced
corpora luteum and subfertility/infertility in female mice (Kim
et al., 2010).
Deletion of ERa in POMC neurons impaired negative feedback
regulation of estrogens on the HPG axis. The negative feedback
is primarily mediated by ERa (Couse et al., 2003). ERa in pituitary
LH cells partially mediates this effect, as deletion of ERa in LH
cells blunts estrogen-induced inhibition on LH secretion (Singh
et al., 2009). Alternatively, estrogens may act on gonadotropin-
releasing hormone (GnRH) neurons in the hypothalamus to
inhibit the HPG axis. As GnRH neurons do not express ERa
(Shivers et al., 1983), interneurons must exist to relay the nega-
tive feedback signals to GnRH neurons. Our observations that
the negative feedback is impaired in ERalox/lox/POMC-Cre
females indicate that POMC neurons may be one of these inter-
neurons. Supporting this notion, ARH POMC neurons project to
the rostral preoptic area, where GnRH neurons are concentrated
(Simonian et al., 1999). The possible signals that originate from
POMC neurons and synapse on GnRH neurons are unclear.
Recent studies from lean hypogonadotropic ewes suggested
that a-MSHmediates leptin effects to restore pulsatile LH secre-
tion (Backholer et al., 2010). Additionally, estrogens are impli-
cated to increase the secretion of another POMC gene product,
b-endorphin (Lagrange et al., 1994), which inhibits GnRH
neurons (Lagrange et al., 1995). These findings support a model
in which estrogens act on ERa in POMC neurons to modulate
secretion of POMC peptides (e.g., a-MSH and/or b-endorphin),
which in turn act on GnRH neurons tomediate the negative feed-
back on the HPG axis.
Other ERa populations in the brain may also contribute to the
negative feedback regulation. For example, Kiss1 neurons are
required for the tonic stimulation of GnRH/LH secretion (Dungan
et al., 2007). Interestingly, Kiss1 neurons in the ARH coexpress
ERa (Cravo et al., 2011), and estrogens reduce ARH Kiss1
expression (Smith et al., 2005). Of note, Kiss1 neurons and
POMC neurons are exclusively segregated in the ARH (Cravo
et al., 2011). Therefore, it is possible that ERa in ARH Kiss1
neurons may provide an alternative pathway, in addition to
ERa in POMC neurons, to mediate the negative feedback.
Conclusions
Using mice lacking ERa in the CNS, in SF1 neurons, in POMC
neurons, and in both SF1 and POMC neurons, we have substan-
tially narrowed down the critical ERa sites thatmediate the estro-
genic effects on energy homeostasis and reproduction. These
results provide genetic evidence to segregate physiological
functions of ERa cells in the context of obesity and infertility,
and may provide rational targets for the development of highly
selective hormone replacement therapies which may be used
to combat obesity and infertility in women.Metabolism 14, 453–465, October 5, 2011 ª2011 Elsevier Inc. 463
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Animals
Care of all animals and procedures were approved by the University of Cincin-
nati, University of Texas Southwestern Medical Center, and Baylor College of
Medicine. Mice were housed in a temperature-controlled environment in
groups of two to five at 22C–24C using a 12 hr light/12 hr dark cycle.
Some cohorts were singly housed to measure food intake. The mice were
fed either standard phytoestrogen-free chow (#2916, Harlan-Teklad, Madison,
WI) or 42% HFD (#88137, Harlan Teklad), and water was provided ad libitum.
Body Weight, Food Intake, and Body Composition
Body weight was measured weekly. Food intake was measured daily, and
average daily food intake was calculated using data from at least four contin-
uous days (7 day data were used in the 5-week-old ERalox/lox/SF1-Cre group).
Body composition was determined using quantitative magnetic resonance
(QMR).
Assessment of Negative Feedback
Twelve-week-old chow-fed female ERalox/lox/POMC-Cre mice and their
ERalox/lox controls were anesthetized with ketamine (100 mg/kg) and xylazine
(10 mg/kg) and received bilateral ovriectomy, followed by subcutaneous
implantations of pellets containing estradiol-17b (0.5 mg/day/mouse with
60 day releasing capacity, OVX+E) or containing vehicle (OVX+V). Four weeks
later, these mice were sacrificed in the afternoon (between 1 and 4 p.m.) after
deep anesthesia. The pituitary was quickly isolated; trunk blood was collected
and processed to collect plasma. Expression of FSH and LH in the pituitary
and plasma FSH/LH were analyzed as described in the Supplemental Exper-
imental Procedures.
Statistics
The data are presented as mean ±SEM. Statistical analyses were performed
using SigmaStat 2.03. After confirming normal distribution of data, compari-
sons between two genotypes were made by the unpaired two-tailed Student’s
t test; repeated measures ANOVA was used to compare changes over time
between two genotypes. Two-way ANOVA analyses were used to assess
the interactions between genotypes and treatments (e.g., saline versus drugs).
p < 0.05 was considered to be statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, two tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.cmet.2011.08.009.
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